Paul Sekhri

Paul Sekhri is a veteran life sciences executive with over thirty years of experience, currently serving as President and Chief Executive Officer of vTv Therapeutics. He is a founding investor at Aditum Bio, launched in 2019 alongside Joe Jimenez and Mark Fishman, and acts as a Senior Advisor for eGenesis after serving as its CEO from 2019 to 2022. Previously, his career featured prominent leadership positions across the pharmaceutical and biotechnology sectors, including Chief Strategy Officer at Teva Pharmaceutical Industries, Senior Vice President at Sanofi, and Senior Vice President at Novartis. Additionally, he has held executive roles such as Operating Partner at TPG Biotech and President and CEO of Lycera Corporation and Cerimon Pharmaceuticals. Sekhri has served as a director on over thirty private, public, and nonprofit boards, with current appointments including Veeva Systems, Longboard Pharmaceuticals, and Ipsen.